Sale of Securities

GeneDx Holdings Corp. Filed 2025-04-09 Acc 0001971857-25-000185

Documents 1

2025-04-16 8-K Material agreement · Unregistered share sale · Regulation FD disclosure
2025-04-14 144 Sale of Securities
2025-04-10 4 CHIEF FINANCIAL OFFICER sold 15,516 shares at an average $92.18 ($1,430,334)
2025-04-10 4 Chief Executive Officer sold 46,594 shares at an average $89.62 ($4,175,817)
2025-04-09 144 Sale of Securities
2025-04-09 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…